Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej W Pruszkowie
- Address
- lock Available on a paid plan
Congenital, Hereditary, and Neonatal Diseases
The pediatric neurology clinic is conducting research on Rett syndrome, a rare genetic neurodevelopmental disorder, to determine whether a new oral agent can improve safety and functional outcomes for affected children.
- Rett syndrome therapeutic development
- Safety assessment of novel oral medications
- Placebo‑controlled efficacy studies
Collaboration with families and local advocacy groups helps the site, Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej W Pruszkowie, to advance care options for children with inherited neurological conditions.
Nervous System Diseases
A separate trial focuses on refractory partial onset epilepsy, evaluating whether an extended‑release formulation of levetiracetam can lower the weekly frequency of focal seizures compared with the standard immediate‑release product.
- Drug‑resistant focal seizure management
- Optimizing seizure control in children
- Comparative formulation effectiveness
Results aim to provide clinicians with clearer guidance on improving quality of life for pediatric patients living with challenging seizure disorders.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Neuraxpharm Pharmaceuticals S.L.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Samodzielny Publiczny Zespol Zakladow Opieki Zdrowotnej W Pruszkowie
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Extended-Release Levetiracetam as Adjunctive Therapy in Refractory Partial Onset Epilepsy: A Randomized, Double-Blind Study | Neuraxpharm Pharmaceuticals S.L. | Phase III | Recruiting | Mar 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Fenfluramine Hydrochloride | 1 | Unknown | 2026-07-14 | 2026-07-14 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.